Asia Medical and Agricultural Laboratory and Research Center Public Company Limited Stocks

THB 3.92Last Updated 27.04.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 48.25M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 3.92
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides laboratory services for the agriculture, food, and pharmaceutical industries in Thailand. The company offers testing, inspection, and certification services for meat and meat products, fats and oils, pet food, feedstuffs and feed raw materials, aquaculture, aquatic animals and aquatic animal products, crops, foods, beverages, water ice, potable water, water, air, and soil; quality control and registration services for fertilizers; quality control, efficacy test, and residue trial and registration services for hazardous substances; and efficacy and residue trial test of pesticides for registration. It also provides quality assurance testing, and research and development services for drugs and raw materials; analysis of components in pharmaceutical products; drug analysis method validation; bioequivalence studies; and quality assurance with contaminant and challenge tests for cosmetics, as well as develops test methods for pharmaceutical products. In addition, the company offers calibration services for electrical and temperature, chemical, and mechanical metrology, as well as for various medical devices, such as electrocardiograms, non-invasive blood pressure devices, patient monitors, pulse oximeters, and electrical safety analyzers; and consultation and training services, which include preparation services for quality system, inspection, certification, and ISO/IEC 17025 and quality system, as well as manages and optimizes tools and equipment. Further, it provides nutrition labeling and shelf-life testing services, and food contact materials. The company was founded in 2004 and is headquartered in Bangkok, Thailand. Asia Medical and Agricultural Laboratory and Research Center Public Company Limited is a subsidiary of Ladprao General Hospital Public Company Limited.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of AMARC.BK is 4.0 and suggests 2% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks